SNTI
Senti Biosciences Holdings, Inc.Company with tickers: SNTI
CIK
1854270
CUSIP
81726A209
Shares Outstanding
31,144,754
Website
https://www.sentibio.com
13F Activity (30d)
3 filings
2 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-09 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Tax | 10,757 |
| 2026-03-09 | Lu Timothy K |
Director, CEO | Tax | 80,666 |
| 2026-02-02 | Lu Timothy K |
Director, CEO | Tax | 4,191 |
| 2026-02-02 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Tax | 1,384 |
| 2025-07-18 | Baum Bryan Daniel |
Director | Other | 0 |
| 2025-07-18 | Baum Bryan Daniel |
Director | Award | 43,900 |
| 2025-06-25 | COOPERSTONE BRENDA |
Director | Award | 21,950 |
| 2025-06-25 | Mathers Edward T |
10% Owner | Award | 21,950 |
| 2025-06-25 | Schulz Fran |
Director | Award | 21,950 |
| 2025-06-25 | Hsiung Feng |
Director | Award | 21,950 |
| 2025-06-25 | Collins James J. |
Director | Award | 21,950 |
| 2025-06-25 | Tang Donald F |
Director | Award | 21,950 |
| 2025-03-10 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Other | 33 |
| 2025-03-10 | Celadon Partners SPV 24 |
10% Owner | Other | 9,777 |
| 2025-03-10 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Other | 33,000 |
| 2025-03-10 | New Enterprise Associates 15, L.P. |
10% Owner | Other | 3,333 |
| 2025-03-10 | BAYER HEALTHCARE LLC |
10% Owner | Other | 2,222 |
| 2025-03-10 | Celadon Partners SPV 24 |
10% Owner | Other | 9,777,000 |
| 2025-03-10 | New Enterprise Associates 15, L.P. |
10% Owner | Other | 3,333,000 |
| 2025-03-10 | BAYER HEALTHCARE LLC |
10% Owner | Other | 2,222,000 |
| 2025-03-07 | COOPERSTONE BRENDA |
Director | Award | 43,900 |
| 2025-03-07 | Tang Donald F |
Director | Award | 43,900 |
| 2025-03-07 | Hsiung Feng |
Director | Award | 43,900 |
| 2025-03-07 | Cross John Harry III |
Chief Financial Officer | Award | 174,200 |
| 2025-03-07 | Lu Timothy K |
Director, CEO | Award | 642,358 |
| 2025-03-07 | Hsiung Feng |
Director | Other | 0 |
| 2025-03-07 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Award | 78,363 |
| 2025-03-07 | Collins James J. |
Director | Award | 43,900 |
| 2025-03-07 | Schulz Fran |
Director | Award | 43,900 |
| 2025-03-07 | Mathers Edward T |
10% Owner | Award | 43,900 |
| 2025-03-06 | Lu Timothy K |
Director, CEO | Award | 1,927,073 |
| 2025-03-06 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Award | 235,088 |
| 2025-03-03 | Cross John Harry III |
Chief Financial Officer | Other | 0 |
| 2025-02-06 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Sell | 182 |
| 2025-02-06 | Lu Timothy K |
Director, CEO | Sell | 545 |
| 2025-02-04 | Lu Timothy K |
Director, CEO | Sell | 3,922 |
| 2025-02-04 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Sell | 1,297 |
| 2024-12-09 | BAYER HEALTHCARE LLC |
10% Owner | Buy | 2,222 |
| 2024-12-09 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Award | 49,500 |
| 2024-12-09 | BAYER HEALTHCARE LLC |
10% Owner | Buy | 3,333,000 |
| 2024-12-09 | Schulz Fran |
Director | Other | 0 |
| 2024-12-09 | Tang Donald F |
Director | Award | 12,500 |
| 2024-12-09 | Schulz Fran |
Director | Award | 12,500 |
| 2024-12-09 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Award | 33 |
| 2024-07-10 | Farokhzad Omid |
Director, CEO AND CHAIR | Award | 62,500 |
| 2024-07-10 | COOPERSTONE BRENDA |
Director | Award | 62,500 |
| 2024-07-10 | Collins James J. |
Director | Award | 62,500 |
| 2024-07-10 | Mathers Edward T |
10% Owner | Award | 62,500 |
| 2024-05-04 | Li Yvonne |
Interim CFO | Other | 0 |
| 2024-02-01 | Rajangam Kanya |
Pres. & Chief Med. & Dev. Off. | Award | 152,000 |
Showing 1–50 of 86 transactions